CXCR2 and atrial fibrillation: To evaluate whether CXCR2 is involved in the development of AF in SHRs, we started to treat 2‐month‐old WKYs and SHRs with the CXCR2 inhibitor SB225002 or vehicle and continued treatment for 4 months.